David De Weese
Business & Management
OSE immuno therapetics
France
Biography
David de Weese has 14 years of operational management experience in Europe and the USA. Mr. De Weese previously held the position of Chief Executive Officer of Machine Intelligence, a software company established in Silicon Valley, and he was the founder, Chairman and Chief Executive Officer of biotechnology companies New York-based – SigA Pharmaceuticals – and California-based – Cygnus Therapeutic Systems). He also founded medical device company, Medical Innovations. Mr. De Weese is currently the company director of the private equity fund Paul Capital, which he joined in 1995.
Research Interest
Operational Management, Medical Innovations
